No Data
BeiGene Executive Wu Xiaobin Sells Over $1 Million in Company Stock
BeiGene Initiated at Outperform at JMP Securities on Strength of Brukinsa
JMP Securities Initiates Coverage On BeiGene With Market Outperform Rating, Announces Price Target of $288
BeiGene Analyst Ratings
BeiGene's TEVIMBRA Gains Approval for OSCC in Israel
JMP Securities Initiates BeiGene(BGNE.US) With Buy Rating, Announces Target Price $288
JMP Securities analyst Reni Benjamin initiates coverage on $BeiGene(BGNE.US)$ with a buy rating, and sets the target price at $288.According to TipRanks data, the analyst has a success rate of 32.4%
No Data
No Data
